Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide Receptors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Not applicableStudy completedNCT06500143
What this trial is testing

Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery

Who this might be right for
Gastric Retention
Ciusss de L'Est de l'Île de Montréal 94
Large-scale testing (Phase 3)Study completedNCT07834398
What this trial is testing

Weekly GLP-1 Receptor Agonists in Obese Individuals Without Diabetes

Who this might be right for
Non-diabetec ObesityObesity (Disorder)
Zagazig University 150
Large-scale testing (Phase 3)Study completedNCT02735031
What this trial is testing

Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Hypoglycemia
Radboud University Medical Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT07523633
What this trial is testing

Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder

Who this might be right for
Cannabis Use DisorderCannabis Use DisordersCannabis Abuse+2 more
Anders Fink-Jensen, MD, DMSci 100
Testing effectiveness (Phase 2)Looking for participantsNCT05938712
What this trial is testing

The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Recipients
University Health Network, Toronto 20
Testing effectiveness (Phase 2)Study completedNCT03232112
What this trial is testing

Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?

Who this might be right for
Alcohol Dependence, in RemissionAddiction, Alcohol
Anders Fink-Jensen, MD, DMSci 152
Not applicableUnknownNCT02887625
What this trial is testing

Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM

Who this might be right for
Type 2 Diabetes
Dr. Muhammad Abdulghani 410
Large-scale testing (Phase 3)Looking for participantsNCT07613307
What this trial is testing

Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting

Who this might be right for
Diabetes Mellitus, Type 2Diabetes MelletusGlucose Metabolism Disorders+13 more
Eli Lilly and Company 130
Post-approval studies (Phase 4)UnknownNCT00473733
What this trial is testing

Glucagon Like Peptides Receptors Expression in the Stomach of Diabetes Type 2

Who this might be right for
Diabetes Mellitus Type 2
Assaf-Harofeh Medical Center
Not applicableWithdrawnNCT06982378
What this trial is testing

GLP-1 RA on Liver OMICS in MASLD

Who this might be right for
NAFLDDiabetesObesity
Medical College of Wisconsin
Testing effectiveness (Phase 2)Study completedNCT07370922
What this trial is testing

Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia

Who this might be right for
Transfusion Dependent Beta Thalassemia
Ain Shams University 80
Not applicableLooking for participantsNCT06069622
What this trial is testing

Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment

Who this might be right for
Overweight and Obesity
Brigham and Women's Hospital 30